Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. [electronic resource] by
- You, Xin
- Pan, Meng
- Gao, Wenli
- Shiah, Her-Shyong
- Tao, Jian
- Zhang, Dongqing
- Koumpouras, Fotios
- Wang, Shuang
- Zhao, Hongyu
- Madri, Joseph A
- Baker, David
- Cheng, Yung-Chi
- Yin, Zhinan
Producer: 20060413
In:
Arthritis and rheumatism vol. 54
Availability: No items available.
|
|
12.
|
Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy. [electronic resource] by
- Liu, Jacqueline Ming
- Chen, Li-Tzong
- Li, Anna F Y
- Wu, Chew Wen
- Lan, Chieh
- Chung, Tsai Rong
- Shiah, Her-Shyong
- Lee, Kuan Der
- Liu, Tsang Wu
- Peng, Jacqueline Whang
Producer: 20050310
In:
Japanese journal of clinical oncology vol. 34
Availability: No items available.
|
|
13.
|
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma. [electronic resource] by
- Shiah, Her-Shyong
- Chao, Yee
- Chen, Li-Tzong
- Yao, Tzy-Jyun
- Huang, Jin-Ding
- Chang, Jang-Yang
- Chen, Pei-Jer
- Chuang, Tsai-Rong
- Chin, Yung-Hsin
- Whang-Peng, Jacqueline
- Liu, Tsang-Wu
Producer: 20061016
In:
Cancer chemotherapy and pharmacology vol. 58
Availability: No items available.
|
|
14.
|
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer. [electronic resource] by
- Shiah, Her-Shyong
- Cheng, Ann-Lii
- Hsu, Chiun
- Hsu, Chih-Hung
- Liu, Tsang-Wu
- Chang, Jang-Yang
- Jan, Chang-Ming
- Chao, Yee
- Yu, Wei-Lan
- Chuang, Tsai-Rong
- Whang-Peng, Jacqueline
- Chen, Li-Tzong
Producer: 20061013
In:
Journal of gastroenterology and hepatology vol. 21
Availability: No items available.
|
|
15.
|
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors. [electronic resource] by
- Kuo, Ching-Chuan
- Liu, Tsang-Wu
- Chen, Li-Tzong
- Shiah, Her-Shyong
- Wu, Ching-Ming
- Cheng, Yen-Ting
- Pan, Wen-Yu
- Liu, Jin-Fen
- Chen, Kuo-Li
- Yang, Yun-Ning
- Chen, Shan-Na
- Chang, Jang-Yang
Producer: 20120518
In:
Free radical biology & medicine vol. 51
Availability: No items available.
|
|
16.
|
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer. [electronic resource] by
- Ch'ang, Hui-Ju
- Wang, Chuan-Cheng
- Cheng, Ann-Lii
- Hsu, Chiun
- Lu, Yen-Shen
- Chang, Ming-Chu
- Lin, Jaw-Town
- Wang, Hsiu-Po
- Shiah, Her-Shyong
- Liu, Tsang-Wu
- Chang, Jang-Yang
- Whang-Peng, Jacqueline
- Chen, Li-Tzong
Producer: 20061031
In:
Journal of gastroenterology and hepatology vol. 21
Availability: No items available.
|
|
17.
|
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. [electronic resource] by
- Ch'ang, Hui-Ju
- Huang, Chin-Lun
- Wang, Hsiu-Po
- Shiah, Her-Shyong
- Chang, Ming-Chu
- Jan, Chang-Ming
- Chen, Jen-Shi
- Tien, Yu-Wen
- Hwang, Tsann-Long
- Lin, Jaw-Town
- Cheng, Ann-Lii
- Whang-Peng, Jacqueline
- Chen, Li-Tzong
Producer: 20090917
In:
Cancer chemotherapy and pharmacology vol. 64
Availability: No items available.
|
|
18.
|
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours. [electronic resource] by
- de Bono, Johann
- Lin, Chia-Chi
- Chen, Li-Tzong
- Corral, Jesus
- Michalarea, Vasiliki
- Rihawi, Karim
- Ong, Michael
- Lee, Jih-Hsiang
- Hsu, Chih-Hung
- Yang, James Chih-Hsin
- Shiah, Her-Shyong
- Yen, Chia-Jui
- Anthoney, Alan
- Jove, Maria
- Buschke, Susanne
- Fuertig, René
- Schmid, Ulrike
- Goeldner, Rainer-Georg
- Strelkowa, Natalja
- Huang, Dennis Chin-Lun
- Bogenrieder, Thomas
- Twelves, Chris
- Cheng, Ann-Lii
Producer: 20201222
In:
British journal of cancer vol. 122
Availability: No items available.
|
|
19.
|
D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. [electronic resource] by
- Juang, Shin-Hun
- Lung, Chia-Chi
- Hsu, Pi-Chen
- Hsu, Kuo-Shun
- Li, Yu-Chen
- Hong, Pao-Chiung
- Shiah, Her-Shyong
- Kuo, Ching-Chuan
- Huang, Ching-Wei
- Wang, Yu-Chin
- Huang, Leeyuan
- Chen, Tom S
- Chen, Shyh-Fong
- Fu, Kuo-Chu
- Hsu, Cheng-Li
- Lin, Meng-Ju
- Chang, Ching-Jer
- Ashendel, Curtis L
- Chan, Thomas C K
- Chou, Kai-Ming
- Chang, Jang-Yang
Producer: 20070316
In:
Molecular cancer therapeutics vol. 6
Availability: No items available.
|